The Claudin18.2 antibody holds significant potential in the treatment of gastric carcinoma. However, due to its non-human sequence and relatively weak receptor affinity, the efficacy and safety of the marketed antibodies still need to be improved. Through hybridoma screening, antibody humanization and modification of antibody-dependent cell-mediated cytotoxicity(ADCC), this study obtained the monoclonal antibody, named 110E2A4-M2, that specifically binds to Claudin18.2. Subsequently, the ADCC and complement-dependent cytotoxicity(CDC) activities of the antibody were determined, and its pharmacological effects were studied in a mouse xenograft tumor model. The results showed that the ADCC activity of 110E2A4-M2 was significantly higher than that of the control antibody(IMAB362), and its CDC activity was not reduced. It displayed a relatively strong tumor-suppressing ability in the mouse subcutaneous xenograft tumor model, with a tumor growth inhibition rate of 52.35%. This study provided data support for the development of Claudin18.2 antibodies.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |